These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31935470)

  • 1. In vivo preclinical evaluation of the new
    Trencsényi G; Kis A; Szabó JP; Ráti Á; Csige K; Fenyvesi É; Szente L; Malanga M; Méhes G; Emri M; Kertész I; Vecsernyés M; Fenyvesi F; Hajdu I
    Int J Pharm; 2020 Feb; 576():118954. PubMed ID: 31935470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
    Csige K; Szabó JP; Kálmán-Szabó I; Dénes NS; Szikra D; Képes Z; Opposits G; Méhes G; Kertész I; Fenyvesi F; Trencsényi G; Hajdu I
    Int J Pharm; 2022 Sep; 625():122132. PubMed ID: 36028082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of tumor targeting potential of
    Szabó JP; Csige K; Kálmán-Szabó I; Arató V; Opposits G; Jószai I; Kertész I; Képes Z; Méhes G; Fenyvesi F; Hajdu I; Trencsényi G
    Int J Pharm; 2023 Jan; 630():122462. PubMed ID: 36462739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Prostaglandin E2 (PGE2)-Targeting Radiolabelled Imaging Probes from Preclinical Perspective: Lessons Learned and Road Ahead.
    Képes Z; Dénes N; Kertész I; Hajdu I; Trencsényi G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemical synthesis and preclinical evaluation of
    Hajdu I; Angyal J; Szikra D; Kertész I; Malanga M; Fenyvesi É; Szente L; Vecsernyés M; Bácskay I; Váradi J; Fehér P; Ujhelyi Z; Vasvári G; Rusznyák Á; Trencsényi G; Fenyvesi F
    Eur J Pharm Sci; 2019 Feb; 128():202-208. PubMed ID: 30521943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative preclinical evaluation of
    Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
    J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.
    Baum RP; Kulkarni HR; Müller D; Satz S; Danthi N; Kim YS; Brechbiel MW
    Cancer Biother Radiopharm; 2015 May; 30(4):152-9. PubMed ID: 25945808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
    Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C
    Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
    Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
    Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.
    Bhatt J; Mukherjee A; Korde A; Kumar M; Sarma HD; Dash A
    Mol Imaging Biol; 2017 Feb; 19(1):59-67. PubMed ID: 27406090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [
    Kálmán-Szabó I; Szabó JP; Arató V; Dénes N; Opposits G; Jószai I; Kertész I; Képes Z; Fekete A; Szikra D; Hajdu I; Trencsényi G
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
    Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [
    Migliari S; Sammartano A; Boss M; Gotthardt M; Scarlattei M; Baldari G; Silva C; Bonadonna RC; Ruffini L
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056858
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in negative charge of
    Rinne SS; Dahlsson Leitao C; Gentry J; Mitran B; Abouzayed A; Tolmachev V; Ståhl S; Löfblom J; Orlova A
    Sci Rep; 2019 Nov; 9(1):17710. PubMed ID: 31776413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative.
    Chakraborty S; Chakravarty R; Vatsa R; Bhusari P; Sarma HD; Shukla J; Mittal BR; Dash A
    Nucl Med Biol; 2016 Jan; 43(1):116-123. PubMed ID: 26527030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
    Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C
    Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.